{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:16:46Z","timestamp":1782494206798,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T00:00:00Z","timestamp":1688860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-03281"],"award-info":[{"award-number":["2018-03281"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejps.2023.106524","type":"journal-article","created":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T17:32:59Z","timestamp":1688923979000},"page":"106524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Exploring the use of modified in vitro digestion assays for the evaluation of ritonavir loaded solid lipid-based formulations"],"prefix":"10.1016","volume":"189","author":[{"given":"Ioannis I.","family":"Andreadis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Schulzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Quodbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8917-2612","authenticated-orcid":false,"given":"Christel A.S.","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejps.2023.106524_bib0001","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1021\/acs.molpharmaceut.8b00699","article-title":"Impact of drug physicochemical properties on lipolysis-triggered drug supersaturation and precipitation from lipid-based formulations","volume":"15","author":"Alsk\u00e4r","year":"2018","journal-title":"Mol. Pharmaceut."},{"issue":"2","key":"10.1016\/j.ejps.2023.106524_bib0002","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1023\/A:1014224900524","article-title":"Experimental and computational screening models for prediction of aqueous drug solubility","volume":"19","author":"Bergstr\u00f6m","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2023.106524_bib0003","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2019.06.010","article-title":"In vitro digestion models to evaluate lipid based drug delivery systems; present status and current trends","volume":"142","author":"Berthelsen","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2023.106524_bib0004","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejpb.2017.05.001","article-title":"Simultaneous lipolysis\/permeation in vitro model, for the estimation of bioavailability of lipid based drug delivery systems","volume":"117","author":"Bibi","year":"2017","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2023.106524_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.biochi.2015.11.016","article-title":"Impact of gastrointestinal lipolysis on oral lipid-based formulations and bioavailability of lipophilic drugs","volume":"125","author":"Carri\u00e8re","year":"2016","journal-title":"Biochimie"},{"issue":"7","key":"10.1016\/j.ejps.2023.106524_bib0006","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1111\/1750-3841.16212","article-title":"A comparative study of in vitro gastrointestinal digestion of three strategic edible oils","volume":"87","author":"Chabni","year":"2022","journal-title":"J. Food Sci."},{"issue":"5","key":"10.1016\/j.ejps.2023.106524_bib0007","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1039\/C6FO00361C","article-title":"Water-in-oil microemulsions versus emulsions as carriers of hydroxytyrosol: an in vitro gastrointestinal lipolysis study using the PHstat technique","volume":"7","author":"Chatzidaki","year":"2016","journal-title":"Food Funct."},{"key":"10.1016\/j.ejps.2023.106524_bib0008","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejps.2013.09.007","article-title":"Fed and fasted state gastro-intestinal in vitro lipolysis: in vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS","volume":"57","author":"Christophersen","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"4","key":"10.1016\/j.ejps.2023.106524_bib0009","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1007\/s11095-015-1843-7","article-title":"A new in vitro lipid digestion \u2013 in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations","volume":"33","author":"Crum","year":"2016","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2023.106524_bib0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2007.01.017","article-title":"The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats","volume":"67","author":"Dahan","year":"2007","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"key":"10.1016\/j.ejps.2023.106524_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120258","article-title":"Simultaneous assessment of in vitro lipolysis and permeation in the mucus-PVPA model to predict oral absorption of a poorly water soluble drug in SNEDDSs","volume":"596","author":"Falavigna","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106524_bib0012","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50 years of oral lipid-based formulations: provenance, progress and future perspectives","volume":"101","author":"Feeney","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.ejps.2023.106524_bib0013","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1007\/s11095-009-9906-2","article-title":"In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol\u00ae and Gelucire\u00ae 44\/14","volume":"26","author":"Fernandez","year":"2009","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.ejps.2023.106524_bib0014","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1007\/s11095-013-1053-0","article-title":"In vitro digestion of the self-emulsifying lipid excipient Labrasol\u00ae by gastrointestinal lipases and influence of its colloidal structure on lipolysis rate","volume":"30","author":"Fernandez","year":"2013","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.ejps.2023.106524_bib0015","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.xphs.2020.04.023","article-title":"Biorelevant two-stage in vitro testing for RDCS classification and in PBPK modeling\u2013case example ritonavir","volume":"109","author":"Fiolka","year":"2020","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejps.2023.106524_bib0016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11095-020-02833-9","article-title":"Suitability of artificial membranes in lipolysis-permeation assays of oral lipid-based formulations","volume":"37","author":"Hedge","year":"2020","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejps.2023.106524_bib0017","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11095-017-2327-8","article-title":"Caco-2 cell conditions enabling studies of drug absorption from digestible lipid-based formulations","volume":"35","author":"Keemink","year":"2018","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2023.106524_bib0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.xphs.2021.09.009","article-title":"Comparison of cellular monolayers and an artificial membrane as absorptive membranes in the in vitro lipolysis-permeation assay","volume":"111","author":"Keemink","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2023.106524_bib0019","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acs.molpharmaceut.8b00811","article-title":"Lipolysis-permeation setup for simultaneous study of digestion and absorption in vitro","volume":"16","author":"Keemink","year":"2019","journal-title":"Mol. Pharmaceut."},{"issue":"9","key":"10.1016\/j.ejps.2023.106524_bib0020","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1021\/acs.molpharmaceut.0c00307","article-title":"Adding a gastric step to the intestinal in vitro digestion model improves the prediction of pharmacokinetic data in beagle dogs of two lipid-based drug delivery systems","volume":"17","author":"Klitgaard","year":"2020","journal-title":"Mol. Pharmaceut."},{"issue":"4","key":"10.1016\/j.ejps.2023.106524_bib0021","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/pharmaceutics13040489","article-title":"Estimating the oral absorption from self-nanoemulsifying drug delivery systems using an in vitro lipolysis-permeation method","volume":"13","author":"Klitgaard","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejps.2023.106524_bib0022","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/jps.1054","article-title":"Physicochemical considerations in the preparation of amorphous ritonavir\u2013Poly(Ethylene Glycol) 8000 solid dispersions","volume":"90","author":"Law","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106524_bib0023","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2023.106524_bib0024","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2007.01.036","article-title":"Development and validation of dissolution test for ritonavir soft gelatin capsules based on in vivo data","volume":"338","author":"Rossi","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2023.106524_bib0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1039\/C5FO00930H","article-title":"Relevant PH and lipase for in vitro models of gastric digestion","volume":"7","author":"Sams","year":"2016","journal-title":"Food Funct."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2023.106524_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2018.02.020","article-title":"Preparation of a solid self-microemulsifying drug delivery system by hot-melt extrusion","volume":"541","author":"Silva","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2023.106524_bib0027","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1208\/s12249-010-9404-1","article-title":"Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir","volume":"11","author":"Sinha","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2023.106524_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105604","article-title":"Effects of lipid digestion and drug permeation\/re-dissolution on absorption of orally administered ritonavir as different lipid-based formulations","volume":"157","author":"Tanaka","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2023.106524_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106079","article-title":"The impact of quantity of lipid based formulations with different compositions on the oral absorption of ritonavir: a trade-off between apparent solubility and permeability","volume":"168","author":"Tanaka","year":"2022","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"9","key":"10.1016\/j.ejps.2023.106524_bib0030","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1021\/mp300298z","article-title":"Incomplete desorption of liquid excipients reduces the in vitro and in vivo performance of self-emulsifying drug delivery systems solidified by adsorption onto an inorganic mesoporous carrier","volume":"9","author":"Van Speybroeck","year":"2012","journal-title":"Mol. Pharmaceut."},{"issue":"8","key":"10.1016\/j.ejps.2023.106524_bib0031","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1080\/10408347.2021.1920364","article-title":"Lopinavir\/ritonavir: a review of analytical methodologies for the drug substances, pharmaceutical formulations and biological matrices","volume":"52","author":"Velozo","year":"2022","journal-title":"Critic. Rev. Analyt. Chem."},{"issue":"7","key":"10.1016\/j.ejps.2023.106524_bib0032","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11095-019-2639-y","article-title":"A proof of concept for 3D printing of solid lipid-based formulations of poorly water-soluble drugs to control formulation dispersion kinetics","volume":"36","author":"Vithani","year":"2019","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejps.2023.106524_bib0033","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1208\/s12248-016-0036-6","article-title":"Inclusion of digestible surfactants in solid SMEDDS formulation removes lag time and influences the formation of structured particles during digestion","volume":"19","author":"Vithani","year":"2017","journal-title":"AAPS J."},{"issue":"6","key":"10.1016\/j.ejps.2023.106524_bib0034","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/jps.23970","article-title":"Lipid-based formulations solidified via adsorption onto the mesoporous carrier neusilin\u00ae US2: effect of drug type and formulation composition on in vitro pharmaceutical performance","volume":"103","author":"Williams","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2023.106524_bib0035","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijpharm.2011.10.037","article-title":"Dissolution of solid lipid extrudates in biorelevant media","volume":"422","author":"Witzleb","year":"2012","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723001549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:06:58Z","timestamp":1760530018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723001549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":35,"alternative-id":["S0928098723001549"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106524","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the use of modified in vitro digestion assays for the evaluation of ritonavir loaded solid lipid-based formulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106524"}}